InvestorsHub Logo
Followers 4
Posts 929
Boards Moderated 0
Alias Born 05/23/2007

Re: None

Monday, 10/15/2007 5:15:57 AM

Monday, October 15, 2007 5:15:57 AM

Post# of 84
So, tonight is the first important news for OSIP: Genentech (DNA) reports Q3 numbers. Then comes Roche & Novartis on Thursday and Merck next Monday. By then we will know how well OSIP did. I hope this quarter is good. This stock has much more potential than what we see in the pps. So, good quartely numbers and a simultaneous approval of Tarceva in Japan would make it jump into the $40+ area. Cross fingers! GLTY

Well, well, well. Have a good day

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.